Skip to main content
Fig. 2 | Asthma Research and Practice

Fig. 2

From: Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy

Fig. 2

Change from baseline versus placebo for selected treatments. For studies requiring patients to be treated with ICS or ICS/LABA at baseline; full covariate analysis. a change from baseline in morning PEF. b change from baseline in FEV1. c annual rate of moderate/severe exacerbations. d AQLQ Total score. AQLQ = Asthma Quality of Life Questionnaire, BUD = budesonide, FORM = formoterol, FEV1 = forced expiratory volume in 1 s, FF = fluticasone furoate, FP = fluticasone propionate, PEF = peak expiratory flow, SAL = salmeterol, VI = vilanterol

Back to article page

Asthma Research and Practice

ISSN: 2054-7064

Contact us